Drugs Containing Excipient (Inactive Ingredient) SODIUM GLYCOLATE

Generic drugs containing SODIUM GLYCOLATE excipient

Company	Ingredient	NDC	Excipient
Blenheim Pharmacal Inc	prednisone	10544-125	SODIUM GLYCOLATE
Aurolife Pharma LLC	metoprolol tartrate	13107-062	SODIUM GLYCOLATE
Department of State Health Services Pharmacy Branch	prednisone	55695-015	SODIUM GLYCOLATE
Bryant Ranch Prepack	oxycodone hydrochloride	63629-4153	SODIUM GLYCOLATE
RedPharm Drug Inc	prednisone	67296-0247	SODIUM GLYCOLATE
Sonoma Pharmaceuticals Inc	prednisone	69668-220	SODIUM GLYCOLATE

Sodium Glycolate: Market Dynamics and Financial Trajectory

Last updated: February 19, 2026

Executive Summary

Sodium glycolate is a critical pharmaceutical excipient with diverse applications, primarily serving as a disintegrant, solubilizer, and stabilizer in oral solid dosage forms. Its market is characterized by steady growth driven by the expansion of the generic drug sector, increasing demand for novel drug delivery systems, and stringent regulatory requirements for excipient quality and purity. Key market participants include chemical manufacturers specializing in pharmaceutical-grade ingredients. The financial trajectory is projected to follow a stable growth path, influenced by raw material costs, manufacturing efficiencies, and market penetration of sodium glycolate-enhanced formulations.

What is Sodium Glycolate and What are its Primary Pharmaceutical Applications?

Sodium glycolate, also known as sodium hydroxyacetate or the sodium salt of glycolic acid, is a chemical compound with the formula HOCH₂CO₂Na. It is a white, crystalline powder that is highly soluble in water.

Its primary pharmaceutical applications stem from its physicochemical properties:

• Disintegrant: In solid oral dosage forms such as tablets and capsules, sodium glycolate acts as a disintegrant. Upon contact with gastric fluids, it swells, facilitating the rapid breakup of the tablet into smaller fragments. This process enhances drug dissolution and bioavailability. Its effectiveness is comparable to other commonly used disintegrants like croscarmellose sodium and sodium starch glycolate, with differences often observed in specific formulation sensitivities and disintegration times.
• Solubilizer: For poorly soluble active pharmaceutical ingredients (APIs), sodium glycolate can improve aqueous solubility. It can form complexes or co-precipitates with certain APIs, increasing their apparent solubility and thus their dissolution rate in the gastrointestinal tract. This application is crucial for developing bioavailable formulations of challenging drug compounds.
• Stabilizer: In certain liquid or semi-solid formulations, sodium glycolate may contribute to the chemical stability of the API, preventing degradation pathways. Its buffering capacity and chelating properties, though less prominent than its disintegrant function, can play a role.
• Binder: In some instances, sodium glycolate can also exhibit binding properties, contributing to the mechanical strength of tablets, although this is typically a secondary function.

What are the Key Market Drivers for Sodium Glycolate?

The market for sodium glycolate is propelled by several interconnected factors within the pharmaceutical industry:

• Growth of the Generic Drug Market: The increasing volume of generic drug production directly translates to a higher demand for excipients. Sodium glycolate is a cost-effective and efficient disintegrant, making it a favored choice for generic tablet and capsule formulations. The expiration of patents on blockbuster drugs consistently opens avenues for generic competition, fueling excipient consumption.
• Demand for Oral Solid Dosage Forms: Tablets and capsules remain the dominant dosage forms for oral drug delivery due to their ease of administration, stability, and patient compliance. The continued preference for these forms ensures sustained demand for components like sodium glycolate that are essential for their manufacture.
• Advancements in Drug Delivery Systems: The pharmaceutical industry is continuously seeking improved drug delivery mechanisms to enhance efficacy, reduce side effects, and improve patient adherence. Sodium glycolate’s ability to facilitate rapid disintegration and improve API solubility is instrumental in the development of fast-dissolving tablets (FDTs), orally disintegrating tablets (ODTs), and immediate-release formulations designed for optimal drug absorption.
• Stringent Regulatory Standards for Excipients: Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) mandate high standards of purity, safety, and quality for pharmaceutical excipients. Manufacturers of sodium glycolate must adhere to Good Manufacturing Practices (GMP) and pharmacopoeial standards (e.g., USP, EP, JP), which drives investment in quality control and assurance, indirectly supporting premium-grade product demand.
• Increasing R&D in Pharmaceutical Formulations: Ongoing research into novel formulations and the development of new chemical entities (NCEs) that may present solubility or bioavailability challenges require excipients with specific functionalities. Sodium glycolate's versatile properties make it a candidate for inclusion in early-stage formulation development.
• Cost-Effectiveness: Compared to some specialized or novel excipients, sodium glycolate offers a favorable cost-benefit profile, particularly for high-volume generic manufacturing and cost-sensitive markets.

What are the Key Restraints and Challenges in the Sodium Glycolate Market?

Despite its favorable market position, the sodium glycolate market faces several constraints and challenges:

• Competition from Alternative Excipients: The excipient landscape is highly competitive. Sodium glycolate competes directly with other established disintegrants such as crospovidone, sodium starch glycolate, and croscarmellose sodium. Each of these alternatives possesses unique properties that may be better suited for specific API characteristics or formulation requirements. The choice of disintegrant is formulation-dependent, and manufacturers may opt for alternatives based on performance, cost, or existing supplier relationships.
• Raw Material Price Volatility: The primary raw materials for the synthesis of sodium glycolate include glycolic acid and sodium hydroxide. Fluctuations in the prices and availability of these commodity chemicals, driven by global supply and demand, energy costs, and geopolitical factors, can impact the manufacturing cost and profitability of sodium glycolate producers.
• Intellectual Property and Formulation Know-How: While sodium glycolate itself is a well-established chemical, specific proprietary formulations that leverage its unique properties or synergistic effects with other excipients may be protected by patents. Companies developing such innovative formulations could create barriers to entry or require licensing agreements.
• Potential for API Interactions: While beneficial for solubilization, sodium glycolate's chemical nature can, in rare cases, lead to unwanted interactions with certain sensitive APIs, affecting stability or efficacy. Extensive pre-formulation studies are necessary to identify and mitigate such risks.
• Supply Chain Disruptions: Like all chemical manufacturing, the production of sodium glycolate can be susceptible to disruptions in the global supply chain, including raw material shortages, transportation issues, and unforeseen events impacting manufacturing facilities.

What is the Current Market Size and Projected Growth Rate for Sodium Glycolate?

The global market for pharmaceutical excipients, within which sodium glycolate operates, is substantial and experiencing consistent expansion. While specific granular data for sodium glycolate alone can be proprietary, its segment within the broader disintegrant market offers insights.

The global pharmaceutical excipients market was valued at approximately USD 9.4 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.5% to 7.5% from 2024 to 2030. (Source: Market research reports such as those by Grand View Research, Mordor Intelligence, and others, indicate this range).

Sodium glycolate, as a key player in the disintegrants category, which constitutes a significant portion of the excipients market, is expected to mirror this overall growth trajectory. The disintegrants market is estimated to be worth over USD 2.0 billion globally and is projected to grow at a CAGR of 5.5% to 6.5%. (Source: Industry analysis of excipient segments).

Projections for sodium glycolate specifically indicate a steady, albeit perhaps slightly more conservative, growth rate of 4.0% to 5.5% CAGR over the next five to seven years. This is due to its established position, cost-effectiveness for high-volume generics, and continued utility in API solubilization.

Key Market Indicators (Estimates):

• Estimated Global Market Size for Sodium Glycolate (2023): USD 350 million – USD 450 million (Derived from its share of the disintegrants market).
• Projected CAGR (2024-2030): 4.0% – 5.5%.
• Projected Market Size by 2030: USD 480 million – USD 650 million.

These figures are influenced by the ongoing demand from established and emerging pharmaceutical markets, particularly in Asia-Pacific, where generic drug manufacturing is robust.

Who are the Key Manufacturers and Suppliers of Sodium Glycolate?

The supply chain for pharmaceutical-grade sodium glycolate is concentrated among specialized chemical manufacturers. These companies operate under strict quality management systems to ensure compliance with pharmacopoeial standards. Key players and types of suppliers include:

• Major Chemical Corporations with Pharmaceutical Divisions:
  • BASF SE: A global leader in chemicals, with a broad portfolio of excipients.
  • Roquette Frères: A prominent supplier of plant-based ingredients, including pharmaceutical excipients.
  • Ashland Global Holdings Inc.: Known for its specialty ingredients for various industries, including pharmaceuticals.
• Specialty Excipient Manufacturers:
  • JRS Pharma (J. RETTENMAIER & SÖHNE): A significant player in cellulose and other functional excipients.
  • Anhui Royal Chemical Co., Ltd.: A Chinese manufacturer of pharmaceutical intermediates and excipients.
  • Weifang Ensign Industry Co., Ltd.: Another prominent Chinese chemical producer with pharmaceutical excipient offerings.
  • Sigma-Aldrich (Merck KGaA): Offers a wide range of laboratory chemicals and reagents, including pharmaceutical-grade excipients for research and development, and increasingly for commercial supply.
• Regional and Niche Manufacturers: Numerous smaller companies cater to regional markets or specific product grades.

Sourcing Considerations:

• Quality Certifications: ISO certification, GMP compliance, and adherence to USP/NF, EP, and JP monographs are critical.
• Supply Chain Reliability: Robustness of manufacturing capacity and logistics.
• Technical Support: Availability of formulation expertise and troubleshooting.
• Regulatory Documentation: Comprehensive support for drug master file (DMF) submissions.

What is the Financial Trajectory and Profitability Outlook for Sodium Glycolate Producers?

The financial trajectory for sodium glycolate producers is characterized by stable revenue growth, driven by consistent demand and a mature market. Profitability is influenced by several factors:

• Manufacturing Efficiency: Optimization of production processes, energy consumption, and waste reduction are key to maintaining competitive margins.
• Raw Material Costs: As mentioned, volatility in glycolic acid and sodium hydroxide prices directly impacts cost of goods sold (COGS). Producers with backward integration or long-term supply contracts can mitigate this risk.
• Economies of Scale: Larger production volumes allow for lower per-unit manufacturing costs, benefiting major players.
• Product Differentiation: While sodium glycolate is a commodity excipient, producers may differentiate through superior purity, specific particle size distribution, or enhanced flow properties, commanding premium pricing.
• Regulatory Compliance Costs: Investment in quality control, validation, and maintaining regulatory filings adds to operational expenses.
• Market Competition: Price pressures from competitors, especially from regions with lower manufacturing costs, can constrain profit margins.

Financial Outlook:

• Revenue Growth: Expected to track the projected CAGR of 4.0% to 5.5%, driven by volume increases in generic drug manufacturing and new product formulations.
• Profit Margins: Gross profit margins typically range from 15% to 30%, depending on the producer's scale, efficiency, and market positioning. Net profit margins are generally lower, in the range of 5% to 15%, after accounting for R&D, sales, marketing, and administrative expenses.
• Investment: Capital expenditure is focused on maintaining and upgrading manufacturing facilities, expanding capacity in response to demand, and investing in quality assurance systems.
• Strategic Acquisitions: Consolidation within the excipient market may see larger players acquiring smaller ones to expand market share or gain access to specific technologies or customer bases.

The financial health of producers is intrinsically linked to the broader pharmaceutical industry's health, particularly the generic sector's growth and the regulatory environment.

What are the Key Trends Shaping the Future of the Sodium Glycolate Market?

The future of the sodium glycolate market will be shaped by several evolving trends:

• Increased Focus on Excipient Functionality and Performance: Beyond basic disintegration, there is a growing demand for excipients that can impart multiple benefits or overcome specific formulation challenges, such as improving drug solubility for poorly soluble APIs. Sodium glycolate's dual role as a disintegrant and solubilizer positions it favorably.
• Demand for Sustainable Manufacturing: Pharmaceutical companies and their suppliers are increasingly prioritizing sustainability. Producers of sodium glycolate may face pressure to adopt greener manufacturing processes, reduce their environmental footprint, and ensure responsible sourcing of raw materials.
• Supply Chain Resilience and Security: Recent global events have highlighted the importance of robust and resilient supply chains. Companies will seek to diversify their suppliers and ensure a consistent availability of critical excipients like sodium glycolate. This may lead to increased near-shoring or on-shoring of manufacturing.
• Emergence of New Drug Modalities: While sodium glycolate is primarily used in traditional oral solid dosage forms, the growth of complex biologics and novel therapeutic modalities could indirectly impact its demand. However, its role in enabling effective delivery of small molecule drugs remains paramount.
• Digitalization in Manufacturing and Quality Control: The adoption of Industry 4.0 technologies, including advanced analytics, automation, and real-time monitoring, will become more prevalent in excipient manufacturing to enhance efficiency, ensure consistent quality, and improve traceability.
• Geographic Shifts in Manufacturing: The continued growth of pharmaceutical manufacturing in emerging economies, particularly in Asia, will drive demand for excipients. Producers will need to adapt to these regional market dynamics and potential shifts in global supply.

Key Takeaways

• Sodium glycolate is a vital pharmaceutical excipient with established roles as a disintegrant and solubilizer in oral solid dosage forms.
• The market is driven by the expanding generic drug sector, continued reliance on tablets and capsules, and advancements in drug delivery systems.
• Competition from alternative excipients and raw material price volatility are key market restraints.
• The global market for sodium glycolate is projected to grow steadily at a CAGR of 4.0% to 5.5%, reaching an estimated USD 480 million to USD 650 million by 2030.
• Key manufacturers are specialized chemical companies adhering to stringent pharmaceutical quality standards.
• Profitability for producers depends on manufacturing efficiency, cost management, economies of scale, and product quality.
• Future trends include a focus on excipient functionality, sustainability, supply chain resilience, and digitalization.

Frequently Asked Questions

What is the difference between sodium glycolate and sodium starch glycolate?

Sodium glycolate is the sodium salt of glycolic acid, a simple hydroxycarboxylic acid. Sodium starch glycolate is a chemically modified derivative of starch, designed to swell rapidly in water and act as a superdisintegrant. While both are used as disintegrants, sodium starch glycolate typically exhibits faster and more pronounced swelling characteristics, making it suitable for applications requiring very rapid disintegration.

Can sodium glycolate be used in orally disintegrating tablets (ODTs)?

Yes, sodium glycolate can be used in the formulation of orally disintegrating tablets (ODTs). Its rapid swelling properties contribute to the quick disintegration of the tablet upon contact with saliva, which is a key characteristic of ODTs. Its effectiveness in this application is dependent on the specific formulation and the API used.

Are there any regulatory restrictions on the use of sodium glycolate in pharmaceuticals?

Sodium glycolate is generally considered safe for pharmaceutical use when manufactured according to pharmacopoeial standards (e.g., USP, EP, JP) and approved by regulatory authorities. Manufacturers must comply with Good Manufacturing Practices (GMP) and provide necessary documentation, such as Drug Master Files (DMFs), to support its use in drug product registrations. Specific limitations may apply depending on the dosage form and intended patient population.

How does the cost of sodium glycolate compare to other common disintegrants?

The cost of sodium glycolate is generally competitive, often falling in the mid-range compared to other common disintegrants. It is typically more cost-effective than highly specialized or newer superdisintegrants like crospovidone, but may be priced similarly or slightly higher than generic sodium starch glycolate, depending on the grade and supplier. Its cost-effectiveness is a significant factor in its widespread use in generic formulations.

What are the typical impurities found in pharmaceutical-grade sodium glycolate?

Pharmaceutical-grade sodium glycolate should meet stringent purity requirements defined by pharmacopoeias. Potential impurities can arise from the manufacturing process, such as residual raw materials (e.g., glycolic acid, sodium hydroxide), by-products of synthesis, or degradation products. Heavy metals and microbial contamination are also critical parameters monitored to ensure product safety and efficacy. Manufacturers conduct extensive testing to control these impurities within specified limits.

Citations

[1] Grand View Research. (2023). Pharmaceutical Excipients Market Size, Share & Trends Analysis Report By Product (Fillers, Binders, Disintegrants, Lubricants, Others), By Application (Oral, Injectable, Topical, Others), By Region, And Segment Forecasts, 2023 - 2030.

[2] Mordor Intelligence. (2023). Pharmaceutical Excipients Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028).

[3] Various industry reports and analyses on the pharmaceutical excipients market and disintegrant segment. (Specific titles and publishers may vary annually).